Leland Gershell
2016 - Capricor Therapeutics
In 2016, Leland Gershell earned a total compensation of $477.2K as Chief Financial Officer at Capricor Therapeutics.
Compensation breakdown
| Option Awards | $263,070 |
|---|---|
| Salary | $214,102 |
| Total | $477,172 |
Gershell received $263.1K in option awards, accounting for 55% of the total pay in 2016.
Gershell also received $214.1K in salary.
Rankings
In 2016, Leland Gershell's compensation ranked 11,355th out of 14,075 executives tracked by ExecPay. In other words, Gershell earned more than 19.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,355 out of 14,075 | 19th |
Division Manufacturing | 4,418 out of 5,486 | 20th |
Major group Chemicals And Allied Products | 1,586 out of 1,900 | 17th |
Industry group Drugs | 1,281 out of 1,543 | 17th |
Industry Pharmaceutical Preparations | 994 out of 1,173 | 15th |
Source: SEC filing on April 21, 2017.
Gershell's colleagues
We found two more compensation records of executives who worked with Leland Gershell at Capricor Therapeutics in 2016.